Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03

Clinical trial NCT04109391 · COMPLETED

Trial details

NCT number: NCT04109391
Sponsor: Tanvex BioPharma USA, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Early-stage Breast Cancer Breast Cancer Breast Neoplasms Stage II Breast Cancer Stage IIIA Breast Cancer

Start date: 2019-08-20
Primary completion: 2021-12-25
Enrollment: 338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.